Nabilone, known as Cesamet, a synthetic imitation of an active ingredient found in marijuana, has been shown successful in treating cancer patients experiencing nausea, pain, anxiety and depression, according to University of Toronto researchers who conducted a study on the effectiveness of the synthetic drug.

During the study of 139 participants, a survey was conducted to rate how well the synthetic drug alleviated the adverse side-effects most commonly associated with chemotherapy. According to the study, cancer patients who were prescribed Cesamet indicated less pain, anxiety and depression.

A prescription drug approved for cancer patients who do not respond to traditional anti-nausea treatments, lead investigator Dr. Vincent Maida stated, "This is not a pot pill and has absolutely no street value."

The trouble with the synthetic drug, which is legal, is the stigma attached to marijuana use in general, even on the part of some physicians, who are said to be hesitant to prescribe a version of marijuana even if it is not marijuana. In our modern society, marijuana is sometimes associated with counter-culture populations, addiction and even as a gateway to more addictive drugs.

I would say I just do not get it when it comes to the denial of making cancer treatment for a cancer patient a little easier, but The Scientific American published a brief history of marijuana that brings us from ancient China to the present with, "In 1937 the U.S. Congress, against the advice of the American Medical Association, passed the Marijuana Tax Act, effectively banning use of the drug by making it expensive and difficult to obtain. Ever since, marijuana has remained one of the most controversial drugs in American society. Despite efforts to change its status, it remains federally classified as a Schedule 1 drug, along with heroin and LSD, considered dangerous and without utility."

As anyone who has undergone the grueling ordeal of chemotherapy can tell you, getting high is the last thing on their mind. However, alleviating the debilitating side effects of chemotherapy is critical.

Other medical marijuana-related posts include:

• Montel Williams: poster child for pot
  
• Medical marijuana pot pill approved for chemotherapy
• Breast cancer has made me a criminal patient story
• FDA rejects medical marijuana use
• Guru of Ganja: medical marijuana advocate faces new pot charges

In a recent study, researchers found that the opiate blocking drug naltrexone, used to treat alcoholics and heroin addicts, was effective in helping some women kick the smoking habit. In addition, the researchers reported that naltrexone prevented the weight gain that often follows when women quit smoking.

Participants in the study were divided into two groups. One group was given a combination of drug therapy, behavioral counseling sessions, and nicotine patches. The other group was given a placebo, behavioral counseling sessions, and nicotine patches. For women receiving naltrexone, 58 percent were still not smoking eight weeks later. Six months later, some had taken up the smoking habit again, but some had remained free of the habit.

Naltrexone did not appear to provide a benefit for men trying to quit smoking.

"Women have historically had less success than men in giving up cigarettes," said study author Andrea King, PhD, associate professor of psychiatry at the University of Chicago. "In this small study, naltrexone seems to have closed that gap."

The study, Efficacy of Naltrexone in Women's Smoking Cessation, is currently ongoing and recruiting new patients.

While public and private groups, along with researchers and a few drug companies, have been making serious efforts to help smokers quit smoking cigarettes, the tobacco industry has been spiking the level of nicotine in cigarettes, according to a study by the Department of Public Health. Between the years 1998 to 2004, the amount of nicotine in cigarettes has risen by ten percent.

According to Lois Keithly , director of the Massachusetts Tobacco Control Program, "We in public health have tried to spend a lot of time figuring out why people don't stop smoking."

Full withdrawal will be felt after the first day of not smoking. But symptoms from nicotine withdrawal are felt within the first 30 minutes after the last cigarette, with smokers reporting cravings within the first hour after the last cigarette. In one hour, smokers reported anger. In three hours of smoking cessation, smokers reported heightened levels of anxiety, sadness and difficulty concentrating. Nicotine is what makes cigarettes so addictive.

The Boston Globe reports when contacted, representatives of the three major tobacco makers in the US declined to comment on the study and would not answer questions about the nicotine content of their products.

The Tobacco Control has published a research paper indicating that teens who smoke just one cigarette at the age of 11 are twice as likely to take up a regular smoking habit in the later teen years than peers who do not experiment with smoking at the same age.

Based on an observational study of young teens in South London, researchers state that their findings provide the first clear evidence of a sleeper effect or period of dormant vulnerability for teenagers who experiment with smoking just one time. It seems just one cigarette rewards a pathway in the brain that is then activated a few years down the road by stress factors, depression or the social pressures typical in a school environment.

The results of the study sound eerily familiar to the way heroin addiction is described, and when I first read it, that is what I kept thinking they were talking about -- heroin addiction. Nicotine is as powerful as heroine in grabbing hold on the user in what becomes a life-long struggle to escape. Available as a PDF document, the research paper is available here.